Johnson & Johnson XNYS: JNJ

Strong Performer, Getting Expensive

Download real time

199.83 0.25 (0.13%)

New 52W High in past week

7.2M

XNYS Volume

XNYS 18 Nov, 2025 1:50 PM (EST)

Acquisition

Johnson & Johnson to acquire Halda Therapeutics for $3.1 bn to expand its prostate cancer portfolio See details

Johnson & Johnson quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents